Company / Operating Cash Flow per Share
Vericel Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$1.05
FY2025
5-year range
-$0.16 / $1.22
FY2021-FY2025
Trend
-14.0%
vs FY2024
Sector context
#54 of 212
Health Care
What the data says
Vericel's operating cash flow per share of $1.05 is higher than 75% of companies in the Health Care sector (FY2025). Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $-1.07 in FY2016 to $1.22 in FY2024.
Based on SEC 10-K filings.
1.05 in FY2025 with a 3-year CAGR of +40.8%.
Improved from $0.75 to $1.05 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +40.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
+107.1% above sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 14.0% year-over-year.
- Ranks #54 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2024.
- Lowest operating cash flow per share in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.05 | -14.0% |
| FY2024 | $1.22 | +62.7% |
| FY2023 | $0.75 | +99.4% |
| FY2022 | $0.37 | +339.0% |
| FY2021 | -$0.16 | -1607.7% |
| FY2020 | -$0.01 | +97.0% |
| FY2019 | -$0.30 | +45.5% |
| FY2018 | -$0.55 | -31.3% |
| FY2017 | -$0.42 | +60.5% |
| FY2016 | -$1.07 | -27.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026